Cary Street Partners Asset Management’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,355
Closed -$12.7K 249
2023
Q1
$12.7K Hold
1,355
﹤0.01% 326
2022
Q4
$16.6K Sell
1,355
-9,340
-87% -$116K ﹤0.01% 336
2022
Q3
$133K Sell
10,695
-23,275
-69% -$407K 0.03% 173
2022
Q2
$667K Buy
33,970
+3,005
+10% +$71.1K 0.16% 109
2022
Q1
$808K Buy
30,965
+49
+0.2% +$1.3K 0.16% 112
2021
Q4
$877K Buy
30,916
+221
+0.7% +$6.87K 0.19% 113
2021
Q3
$979K Sell
30,695
-772
-2% -$25.9K 0.35% 85
2021
Q2
$1.09M Sell
31,467
-32,483
-51% -$1.07M 0.26% 91
2021
Q1
$967K Buy
63,950
+3,709
+6% +$114K 0.24% 96
2020
Q4
$997K Buy
+60,241
New +$1.84M 0.29% 84

Other funds holding ELAN

Cary Street Partners Asset Management's ELAN Position: Q2 2023 in Review

Cary Street Partners Asset Management sold out of Elanco Animal Health (ELAN) in Q2 2023, closing a stake of 1,355 shares — an estimated $12.7K sold.

Cary Street Partners Asset Management first reported a position in ELAN in Q4 2020 and held it in 10 quarters. The position peaked at $1.09M in Q2 2021. 352 funds tracked by Wall St. Rank hold ELAN as of Q2 2023.

  • Cary Street Partners Asset Management reported no remaining Elanco Animal Health position as of Q2 2023 after selling out during the quarter.
  • Cary Street Partners Asset Management sold 1,355 Elanco Animal Health shares in Q2 2023, an estimated $12.7K.
  • Cary Street Partners Asset Management first reported a position in Elanco Animal Health in Q4 2020 and held it in 10 quarters.
  • Cary Street Partners Asset Management's Elanco Animal Health position peaked at $1.09M in Q2 2021.
  • 352 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2023.

Based on Cary Street Partners Asset Management's 13F filing for Q2 2023, filed 10 Aug 2023.